The Grand Tour - Classic Nine Peaks

KTS began climbing in the summer of 2002 marking Kate's 10th year with T1D.  Since KTS teams reached the summit of Mt. Rainier in 2004, KTS has climbed to help finance clinical trials of a potential cure for T1D being conducted by Dr. Faustman and her team at Massachusetts General Hospital.  The trials are looking at BCG vaccine, an inexpensive and already generic drug that's been safely used over 4 billion times in the last 100 years to combat TB.  As KTS teams have climbed hundreds of miles and tens of thousands vertical feet, Phase 1 of the clinical trials were fully funded and over $20 million has been raised to fund Phase II, and Phase II of the clinical trials were launched. 

In June 2017, Dr. Faustman presented the interim results of the BCG clinical trials research at the 77th Scientific Sessions of the American Diabetes Association and reported that the vaccine could permanently reverse T1D.  With this news, we may be approaching the watershed on the journey to conquer T1D.  To mark this news and KTS' 15th year in August, to recognize Kate's birthday in her 25th year with T1D and to #finishmurphsclimb we will hike the 25+ mile Grand Tour in two days and attempt to summit the "Classic Nine Peaks" of the San Gorgonio Wilderness, including San Gorgonio Mountain (Old Greyback) the highest peak in Southern California at 11,503 feet (3,506 m), and one of the most topographically prominent peaks in the US, ranked 7th among peaks in the 48 contiguous states.

Please follow us on Facebook and Instagram and help us reach our goal to Conquer Diabetes. Every dollar donated will go to support the Phase II Clinical Trials testing the generic vaccine BCG to reverse advanced T1D.  We appreciate every dollar donated and can't thank you enough for helping to find a cure for this though disease.

The Grand Tour
Great Western Divide